Researchers in Dr. Andrei Krassioukov’s laboratory are investigating the effects of non-invasive (transcutaneous) spinal cord stimulation (TCSCS) on bladder, bowel, and sexual function in people with SCI. They are interested in both the immediate effects of non-invasive stimulation on these functions, and the long term effects (after 6 weeks of regular use).
You may be eligible to participate if you
- are a BC resident with active medical services plan
- are 18-65 years old
- > 1-year traumatic spinal cord injury at or above T6
- have a motor-complete spinal cord injury (AIS A or B)
- experience bladder and bowel dysfunction
- do not have moderate or severe renal dysfunction
Eligible participants enrolled into the study will be asked to attend either 19 or 37 visits (depending on whether they are selected for the “moderate” or “intense” TCSCS group) at ICORD over the course of about 5 months. There will also be 1 visit at St. Paul’s Hospital, and 2 visits by phone or virtual teleconference (e.g., Zoom). These visits will include assessments of your bladder, bowel, and sexual function, and application of non-invasive transcutaneous spinal cord stimulation.
Most visits will take place at Dr. Krassiouikov’s labs at the Blusson Spinal Cord Centre, with one visit at St. Paul’s Hospital and two visits by phone or virtual teleconference.
For more information or to sign up to participate, please contact the study coordinator, Laura McCracken